Literature DB >> 27216797

Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment?

Aaron Liew1,2,3, James Douketis4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27216797     DOI: 10.1007/s11739-016-1463-1

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  39 in total

Review 1.  Systematic review with meta-analysis: the risk of major gastrointestinal bleeding with non-vitamin K antagonist oral anticoagulants.

Authors:  D Caldeira; M Barra; A Ferreira; A Rocha; A Augusto; F J Pinto; J Costa; J J Ferreira
Journal:  Aliment Pharmacol Ther       Date:  2015-10-04       Impact factor: 8.171

2.  Symptomatic hepatocellular liver injury with hyperbilirubinemia in two patients treated with rivaroxaban.

Authors:  Evangelia Liakoni; Alexandra E Rätz Bravo; Luigi Terracciano; Markus Heim; Stephan Krähenbühl
Journal:  JAMA Intern Med       Date:  2014-10       Impact factor: 21.873

3.  Pharmacokinetics and pharmacodynamics of enoxaparin in multiple trauma patients.

Authors:  Curtis E Haas; Jamie L Nelsen; Krishnan Raghavendran; William Mihalko; Joseph Beres; Qing Ma; Alan Forrest
Journal:  J Trauma       Date:  2005-12

4.  Vascular disorders of the liver.

Authors:  Laurie D DeLeve; Dominique-Charles Valla; Guadalupe Garcia-Tsao
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

5.  Successful treatment of acute portal vein thrombosis with rivaroxaban.

Authors:  Sven Pannach; Jana Babatz; Jan Beyer-Westendorf
Journal:  Thromb Haemost       Date:  2013-07-11       Impact factor: 5.249

Review 6.  Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies.

Authors:  Xingshun Qi; Valerio De Stefano; Hongyu Li; Junna Dai; Xiaozhong Guo; Daiming Fan
Journal:  Eur J Intern Med       Date:  2015-01-05       Impact factor: 4.487

7.  Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study.

Authors:  Esther W Chan; Wallis C Y Lau; Wai K Leung; Michael T C Mok; Ying He; Teresa S M Tong; Ian C K Wong
Journal:  Gastroenterology       Date:  2015-05-08       Impact factor: 22.682

8.  Impact of new oral anticoagulants on gastrointestinal bleeding in atrial fibrillation: A meta-analysis of interventional trials.

Authors:  Lorenzo Loffredo; Ludovica Perri; Francesco Violi
Journal:  Dig Liver Dis       Date:  2015-02-07       Impact factor: 4.088

9.  Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis.

Authors:  Jung Wha Chung; Gi Hyun Kim; Jong Ho Lee; Kyeong Sam Ok; Eun Sun Jang; Sook-Hyang Jeong; Jin-Wook Kim
Journal:  Clin Mol Hepatol       Date:  2014-12-24

10.  International normalized ratio of prothrombin time in the model for end-stage liver disease score: an unreliable measure.

Authors:  Russ Arjal; James F Trotter
Journal:  Clin Liver Dis       Date:  2009-02       Impact factor: 6.126

View more
  1 in total

Review 1.  The 2016 American College of Chest Physicians treatment guidelines for venous thromboembolism: a review and critical appraisal.

Authors:  James Demetrios Douketis
Journal:  Intern Emerg Med       Date:  2016-10-20       Impact factor: 3.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.